The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Size Of The Cardiac Valve Market Progress Through 2030?
The cardiac valve market size has experienced rapid growth in recent years. It is projected to expand from $12.41 billion in 2025 to $14.24 billion in 2026, at a compound annual growth rate (CAGR) of 14.8%. The expansion observed in the historic period can be attributed to the rising occurrence of valvular heart diseases, the broadening of cardiac surgery programs, the increasing application of mechanical heart valves, ongoing advancements in surgical valve techniques, and the enhanced availability of cardiac care facilities.
The cardiac valve market is projected to experience substantial expansion in the coming years, reaching an estimated value of $24.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.0%. This anticipated growth is attributed to factors such as the increasing demand for transcatheter interventions, a growing focus on cardiac care for older adults, the development of hybrid cardiac procedures, escalating investments in advanced valve technologies, and the wider adoption of patient-specific valve solutions. Significant trends expected in this period include the rising acceptance of transcatheter valve procedures, an increasing demand for bioprosthetic heart valves, a growing preference for minimally invasive valve replacement, the expansion of sophisticated valve repair techniques, and an enhanced emphasis on valve durability and performance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp
What Key Growth Drivers Are Influencing The Cardiac Valve Market?
The increasing occurrence of cardiovascular diseases is anticipated to boost the growth of the cardiac valve market. The prevalence of cardiovascular disease has steadily climbed due to factors such as smoking, obesity, insufficient physical activity, and other elements that burden the cardiovascular system. The primary cause of coronary artery disease is the accumulation of fatty plaques within the arteries. These incremental rises in heart-related ailments have amplified the demand for cardiac valves to address heart valve problems. For instance, in October 2024, according to the Centers for Disease Control, a US-based government agency, in 2023, approximately 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Therefore, the escalating incidence of cardiovascular diseases will stimulate the expansion of the cardiac valve market.
How Is The Cardiac Valve Market Examined Through Segment Analysis?
The cardiac valve market covered in this report is segmented –
1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves
2) By Position: Aortic Valve, Mitral Valve, Other Positions
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users
Subsegments:
1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves, Transcatheter Mitral Valve Replacement (TMVR) Valves
3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves
Which Trends Are Influencing The Expansion Of The Cardiac Valve Market?
Major companies operating in the cardiac valve market are prioritizing the development of technological advancements, such as transfemoral transcatheter mitral valve replacement (TMVR) systems, to cater to the escalating demand for minimally invasive therapies within an aging population experiencing a rise in mitral regurgitation rates. A transfemoral TMVR system functions by utilizing a collapsible frame and biologic valve leaflets, which can be deployed through a catheter inserted via the femoral vein, thus circumventing open-heart surgery and leading to shorter recovery times, diminished procedural risk, and improved suitability for patients who are unable to undergo traditional surgery. For instance, in April 2025, Edwards Lifesciences, a U.S.-based medical device company, secured CE Mark approval for its SAPIEN M3 System, representing the first transcatheter mitral valve replacement therapy delivered via a transfemoral approach. The SAPIEN M3 integrates a docking mechanism that initially secures the native mitral leaflets and chordae by pulling them inward to establish a stable landing zone, followed by the subsequent deployment of a bioprosthetic valve, both of which are delivered through a steerable 29 F guide sheath. This design facilitates precise placement, repositioning, and retrieval before final deployment, thereby enhancing procedural safety and expanding treatment availability to patients ineligible for surgery or edge-to-edge repair.
Which Companies Are Influencing The Cardiac Valve Market?
Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomédica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl
Access The Complete Cardiac Valve Market Report:
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report
Which Region Accounts For The Highest Share Of The Cardiac Valve Market?
North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Cardiac Valve Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=7753&type=smp
Browse Through More Reports Similar to the Global Cardiac Valve Market 2026, By The Business Research Company
Prosthetic Heart Valve Devices And Equipment Market Report 2026
Cardiovascular Surgery Devices And Equipment Market Report 2026
Cardiovascular Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model